Sanjay K. Banerjee, et.al., A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia., Biochemical and biophysical research communications, 2007, 360

http://rdf.ncbi.nlm.nih.gov/pubmed/17597581

Sanjay K. Banerjee, et.al., A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia., Biochemical and biophysical research communications, 2007, 360

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD20275
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD20275

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Myh6-PRKAG2*T400N)1Feah
  http://metadb.riken.jp/db/mgi_rdf/MGI:4818807

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased heart weight_Tg(Myh6-Prkaa2*D157A)1Rti/0,Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0002833IFVBTgMyh6Prkaa2D157A1Rti0TgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1FeahTgMyh6Prkaa2D157A1Rti
• abnormal heart left ventricle morphology_Tg(Myh6-Prkaa2*D157A)1Rti/0,Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0003921IFVBTgMyh6Prkaa2D157A1Rti0TgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1FeahTgMyh6Prkaa2D157A1Rti
• abnormal impulse conducting system conduction_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0003137IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• shortened PR interval_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0010511IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• dilated heart left ventricle_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0002753IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• increased response of heart to induced stress_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0004485IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• abnormal myocardial fiber morphology_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0000278IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• decreased ventricle muscle contractility_Tg(Myh6-Prkaa2*D157A)1Rti/0,Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0005598IFVBTgMyh6Prkaa2D157A1Rti0TgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1FeahTgMyh6Prkaa2D157A1Rti
• increased heart weight_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0002833IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• decreased ventricle muscle contractility_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0005598IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• prolonged QRS complex duration_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0010392IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• increased cardiac muscle glycogen level_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0014071IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• increased cardiac muscle glycogen level_Tg(Myh6-Prkaa2*D157A)1Rti/0,Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0014071IFVBTgMyh6Prkaa2D157A1Rti0TgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1FeahTgMyh6Prkaa2D157A1Rti
• abnormal heart left ventricle morphology_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0003921IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah
• increased myocardial infarction size_Tg(Myh6-PRKAG2*T400N)1Feah/0
  http://metadb.riken.jp/0003037IFVBNTgMyh6PRKAG2T400N1Feah0TgMyh6PRKAG2T400N1Feah